Benzinga | Nov 5, 2021 09:29AM EDT

Chembio Diagnostics Q3 EPS $(0.24) Misses $(0.22) Estimate, Sales $12.10M Beat $11.50M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $12.10 million which beat the analyst consensus estimate of $11.50 million by 5.22 percent. This is a 17.80 percent increase over sales of $10.27 million the same period last year.